BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24475870)

  • 1. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas.
    AlQahtani A; Touitou V; Cassoux N; Aknin C; Merle-Beral H; Bodaghi B; LeHoang P
    Ocul Immunol Inflamm; 2014 Jun; 22(3):189-96. PubMed ID: 24475870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of cell block method for vitreoretinal lymphoma.
    Kase S; Namba K; Iwata D; Mizuuchi K; Kitaichi N; Tagawa Y; Okada-Kanno H; Matsuno Y; Ishida S
    Diagn Pathol; 2016 Mar; 11():29. PubMed ID: 26987877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic procedures in vitreoretinal lymphoma.
    Dalal M; Casady M; Moriarty E; Faia L; Nussenblatt R; Chan CC; Sen HN
    Ocul Immunol Inflamm; 2014 Aug; 22(4):270-6. PubMed ID: 24377379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
    Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
    Levasseur SD; Wittenberg LA; White VA
    JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
    Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
    Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma.
    de Hoog J; Dik WA; Lu L; Heezen KC; Ten Berge JC; Swagemakers SMA; van der Spek PJ; van Dongen JJM; van der Velden VHJ; Rothova A; Langerak AW
    Acta Ophthalmol; 2019 Sep; 97(6):626-632. PubMed ID: 30688042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma.
    Ito T; Takeda A; Fujiwara K; Hasegawa E; Nakao S; Ohishi Y; Oda Y; Yoshikawa H; Sonoda KH
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):1029-1036. PubMed ID: 30868235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series.
    Cimino L; Coassin M; Chan CC; Marchi S; Belpoliti M; Fanti A; Iovieno A; Fontana L
    Indian J Ophthalmol; 2016 May; 64(5):369-75. PubMed ID: 27380976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
    Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
    Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
    Delhiwala K
    Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze.
    Marchese A; Miserocchi E; Giuffrè C; Cicinelli MV; Querques G; Bandello F; Modorati G
    Br J Ophthalmol; 2019 Nov; 103(11):1656-1659. PubMed ID: 30709808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
    Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
    Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
    Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIFFERENTIAL DIAGNOSIS FOR VITREORETINAL LYMPHOMA WITH VITREORETINAL FINDINGS, IMMUNOGLOBULIN CLONALITY TESTS, AND INTERLEUKIN LEVELS.
    Lee J; Kim SW; Kim H; Lee CS; Kim M; Lee SC
    Retina; 2019 Jun; 39(6):1165-1176. PubMed ID: 29474309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
    Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
    Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.